Origin	China
Brand Name	perfectha

Description

Perfectha graft is a purified viscous and transparent gel, presented in a glass syringe jointly with 2 needles. It is a single use product. Perfectha graft is a unique stabilized hyaluronic acid of non animal origin. The hyaluronic acid is a natural polysaccharide present in the skin, in the subcutaneous and in the connective tissues acting as synovial fluid. The hyaluronic acid is one of the few substances having an identical form in all living oranisms.

Mode of action

Perfectha graft allows the increment of the skin and lips volume. It restores the contour of the former and accentuates the shape of the latter so that the desired level of correction can be attained. The importance is naturally integrated in the tissues and as time goes by it will undergo an isovolemic degradation.

Sterilization

The syringe containing Perfectha graft is sterilized by steam. The needle is sterilized by means of gamma radiation.

Indication

Perfectha graft is indicated for facial tissue increase. This product is recommended for wrinkles correction and lips enhancement. It must be injected in the medium layer of the facial skin dermis. Better results regarding the deformities of the cutaneous contour will be obtained if its defects can be manually stretched until their complete elimination. Up to what level and durations the correction will last will depend on the type of effect treated, stress at the graft implant spot, depth of implant within the tissue ad the adopted injection technique. More serious defects may be hard to correct.

Warning

Perfectha graft is to be used only by intradermal via. Do not resterilize Perfectha graft. Do not inject intravascularly. Do not mix with other products.

Precaution

Normal precaution measures associated with intradermic injections must be observed. As with any other procedure of the kind, implants are associated with a risk of injection.

Perfectha must not be used close or in anatomic locations where there are active pathologies of the skin, inflammations or related conditions. Do not uses Perfectha in association to any other inject able implant.

The product must not be injected in areas where a permanent implant was inserted or in patients having unreal expectations.

Patients must be informed that they must not expose the treated region to intense heat (as sun bathing) or extreme cold, at least until the initial light edema and erythema disappear.

If a chemical “peeling” or other procedure based on a dermal active response is to be effected after the implant with Perfectha Derm graft there is a theoretical risk of reaction at the implant spot. The same can occur if Perfectha Derm graft is applied before the skin completely recovers from this type of procedure.

There is a potential risk of accidental injection of materials in blood vessels of the dermis which might generate vascular occlusion in a terminal artery, with the correspondent consequences. Up to now, there are no reported cases of this occurrence with Perfectha Derm. The product has not been tested neither no pregnant or nursing women, nor on children.